Logo
M

MSD ANIMAL HEALTH VIETNAM CO., LTD.

For more than a century, MSD Animal Health, a leading global pharmaceutical company, has
Country/AreaVietnam
IndustryManufacturing GeneralManufacturing
Company website
Company phone+27 119239300
Established1968
Company Revenue$24,659,000
Number of employees186
SIC Code28283
NAICS Code32325
https://www.linkedin.com/showcase/msd-animal-healthhttps://twitter.com/msdanimalhealthhttp://www.facebook.com/msd.animal.health.eshttps://www.youtube.com/channel/uczch6j3eqrpbxtg9gslfd8q

Company News

MSD Animal Health to Acquire Assets of LIC Automation Ltd.
MADISON, N.J.--(BUSINESS WIRE)--MSD Animal Health to Acquire Assets of LIC Automation Ltd.
Scientists Outline The Hidden Risk Of Seasonal Changes On Our Pets' Health
59% of pet owners surveyed are unaware of the impact of seasonal change on their dogs and cats 21 leading European scientists confirm warmer weather poses a threat to pet health BRUSSELS, Oct. 5, 2020 /PRNewswire/ -- MSD Animal Health announced the Protect Our Future Too campaign...
Virbac completes divestment of U.S. Rights to SENTINEL® brands to MSD Animal Health
Virbac, today announced the successful completion of its divestment of the U.S. rights to its parasiticides for dogs: SENTINEL® FLAVOR TABS® and SENTINEL® SPECTRUM® to MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK). The consideration received for the transaction amounted to approximately US $400 million, subject to customary closing adjustments, settled in cash.
Virbac to divest U.S. Rights to SENTINEL® brands to MSD Animal Health
Virbac announces that it has entered into an agreement with MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), to divest veterinary products currently marketed in the United States under the SENTINEL® brands by Virbac, for US $400 million in an all-cash deal subject to customary post-closing adjustments. These assets were acquired in early 2015 from Eli Lilly.

Web Summary

Q1: What is the company name and its location?
A1: The company name is MSD Animal Health Vietnam Co., Ltd., but it seems that this information is not explicitly mentioned in the provided text. However, based on the copyright notice at the end of the page, it is stated that "We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co., Inc., Rahway, NJ USA". This suggests that MSD Animal Health Vietnam Co., Ltd. might be a subsidiary or branch office of Merck & Co., Inc.

Q2: What products does the company offer?
A2: The provided text mentions several products offered by MSD Animal Health, including BRAVECTO (fluralaner) for dogs, which offers unparalleled duration of flea and tick protection compared to existing products. Additionally, it mentions NOBILIS MULTRIVA, a product that has received a positive CVMP opinion.

Q3: What industry does the company operate in?
A3: MSD Animal Health operates in the animal health industry, specifically focusing on companion animals, equine, swine, poultry, ruminate, and aquaculture.

Q4: What services does the company provide?
A4: The company provides various services, including product quality and safety assessments, animal health and welfare policies and positions, careers, and contact information for media inquiries.

Q5: Who is Laurie Hueneke Martens and what award did she receive?
A5: Laurie Hueneke Martens is an associate vice president of Global Public Policy and Government Relations at MSD Animal Health. She received the "Feather in Her Cap" Award for Contributions to the Animal Health Industry from the Feather in Her Cap Association.

Q6: What is the company's commitment to sustainability and responsibility?
A6: The company is committed to focusing on sustainability, investing in tomorrow’s veterinarians and associated professionals, and preserving and improving the health, well-being, and performance of animals through science.

Q7: How did S&P Global Animal Health award BRAVECTO (fluralaner)?
A7: S&P Global Animal Health awarded the injectable formulation of BRAVECTO (fluralaner) the 2024 Best New Companion Animal Product for its unparalleled duration of flea and tick protection compared to existing products.

Q8: What is the company's approach to innovation?
A8: The company fosters innovation through its team of scientists and researchers, who are committed to advancing the state of veterinary medicine and developing new technologies and solutions to improve animal health.
Customs Data
As a purchaser
As a Supplier
Disable_icon
Get the Whole details
DisableData_png
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Disable_icon
Get the Whole details
DisableContact_png